Orbimed Advisors - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$32,752,369
-22.4%
958,793
-12.5%
0.70%
-9.0%
Q2 2023$42,196,000
+2.6%
1,096,000
-4.6%
0.76%
-5.2%
Q1 2023$41,126,289
-9.2%
1,149,1000.0%0.81%
-6.9%
Q4 2022$45,309,013
+10.4%
1,149,100
+1.0%
0.87%
+13.8%
Q3 2022$41,057,000
+1.5%
1,137,300
-14.4%
0.76%
+4.0%
Q2 2022$40,434,000
+92.8%
1,329,200
+93.8%
0.73%
+115.6%
Q1 2022$20,971,000
+6.4%
686,000
+8.7%
0.34%
+34.4%
Q4 2021$19,712,000
+170.4%
631,000
+32.3%
0.25%
+216.2%
Q3 2021$7,289,000
-70.7%
477,000
-64.2%
0.08%
-68.1%
Q2 2021$24,843,000
-44.4%
1,334,217
-46.6%
0.25%
-40.0%
Q1 2021$44,713,000
+16.4%
2,497,9170.0%0.42%
+24.4%
Q4 2020$38,418,000
+38.9%
2,497,9170.0%0.34%
-3.4%
Q3 2020$27,652,000
-11.7%
2,497,9170.0%0.35%
-21.1%
Q2 2020$31,324,000
+66.1%
2,497,917
+50.2%
0.44%
+39.1%
Q1 2020$18,856,000
+126.6%
1,662,812
+161.9%
0.32%
+166.4%
Q4 2019$8,322,000
+45.5%
634,8120.0%0.12%
+9.2%
Q3 2019$5,720,000
-8.6%
634,8120.0%0.11%
+12.4%
Q2 2019$6,259,000
-3.0%
634,8120.0%0.10%
-3.0%
Q1 2019$6,450,000
+61.0%
634,8120.0%0.10%
+35.1%
Q4 2018$4,006,000
-52.2%
634,8120.0%0.07%
-26.7%
Q3 2018$8,380,000
+43.5%
634,8120.0%0.10%
+44.3%
Q2 2018$5,840,000
+87.7%
634,8120.0%0.07%
+79.5%
Q1 2018$3,111,000
+73.5%
634,8120.0%0.04%
+69.6%
Q4 2017$1,793,000
-4.3%
634,8120.0%0.02%
+27.8%
Q3 2017$1,873,000
-6.4%
634,8120.0%0.02%
-14.3%
Q2 2017$2,000,000
-21.2%
634,8120.0%0.02%
-27.6%
Q1 2017$2,539,000
-67.0%
634,812
-36.5%
0.03%
-70.4%
Q4 2016$7,700,000
-4.9%
1,000,0000.0%0.10%
+6.5%
Q3 2016$8,100,0001,000,0000.09%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders